Early Access — free while we kick the tires
EdgarHawk

Anderson Thomas

Director

Director
1 filing analyzed · 1 company · Latest 2024-07-16

Companies

Company Buys Sells Direction
ZEVRA THERAPEUTICS, INC. ZVRA 1 0 Net buying

Activity

July 2024
high
Buy
10,000 shares
$68,065
Significance 6/10

Director Anderson Thomas doubled ZVRA holding to 20,000 shares, buying 10,000 at $6.81 on 2024-07-16 amid +40.6% 30-day rally.

Anderson Thomas (Director) purchased 10,000 shares at $6.81 on 2024-07-16, doubling his stake from 10,000 to 20,000 shares and committing $68.1K to the transaction. The purchase occurred during strong recent price momentum: ZVRA has gained +40.6% over the past 30 days and +41.0% over 90 days, though the stock currently trades at $6.54, -7.6% from its 52-week high of $7.08. Thomas's prior buy at this ticker on 2023-09-06 generated a +3.8% return over the subsequent 90 days, indicating he has previously timed entries at ZVRA advantageously. However, the company remains unprofitable with net income of $-16.6M against quarterly revenue of $3.4M, despite strong annual revenue growth of +162.6%, which underscores the speculative nature of the position and the importance of tracking whether this transaction's timing will replicate the insider's prior success at this ticker.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access